PMV Pharmaceuticals ROA Ratio 2011-2026 | PMVP

Annual ROA Ratio PMV Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-66.7	-30.69	-27.35	-27.12	-17.45	-9.42	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-9.42	-66.7	-29.79

Quarterly ROA Ratio PMV Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-48.43	-41.3	-27.94	-9.11	-15.49	-13.26	-19.95	-21.11	-27.5	-27.52	-26.08	-18.01	-22.37	-20.33	-18.19	-11.25	-13.65	-11.69	-10.25	-6.56	-12.56	-16.15	-13.97	-5.99	-5.99	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-5.99	-48.43	-18.59

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Biohaven Pharmaceutical Holding Company Ltd. BHVN	-78.59	$ 9.21	-	$ 596 M	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	-7.29	$ 0.87	-2.13 %	$ 6.4 M	China
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	19.07	$ 22.43	1.04 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	-117.57	-	-	$ 10.1 M	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-275.96	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	65.02	$ 104.31	2.69 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	-1008.51	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-19.87	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	-19.74	$ 1.44	-3.36 %	$ 235 M	France
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
Allakos ALLK	-76.23	-	-	$ 28.6 M	USA
AlloVir ALVR	-35.68	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	-103.3	$ 3.06	2.34 %	$ 5.04 M	Israel
Ampio Pharmaceuticals AMPE	-150.49	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
Applied Therapeutics APLT	-218.41	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	-254.37	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	-52.23	$ 4.08	0.83 %	$ 436 M	USA
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-122.8	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	-206.68	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	-3.73	$ 22.93	2.48 %	$ 2.92 B	USA
Allena Pharmaceuticals ALNA	-140.01	-	3.16 %	$ 1.9 M	USA
Edesa Biotech EDSA	-161.77	$ 15.77	-0.82 %	$ 50.4 M	USA
Athira Pharma ATHA	-114.6	-	-	$ 269 M	USA
Alpine Immune Sciences ALPN	-20.15	-	-	$ 2.17 B	USA
Avenue Therapeutics ATXI	-99.25	-	-52.27 %	$ 4.45 M	USA
Aileron Therapeutics ALRN	-206.44	-	10.36 %	$ 9.8 M	USA
Autolus Therapeutics plc AUTL	-48.81	$ 1.43	1.06 %	$ 381 M	Britain
AVROBIO AVRO	12.03	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	0.11	-	-	$ 96.9 B	Britain
Evogene Ltd. EVGN	-39.9	$ 0.76	0.71 %	$ 27.9 M	Israel
Atreca BCEL	-62.67	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	26.14	-	-4.8 %	$ 255 M	USA
Exelixis EXEL	27.51	$ 45.02	0.73 %	$ 12.2 B	USA
BeiGene, Ltd. BGNE	3.5	-	0.49 %	$ 251 B	Cayman-islands